It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: ElectricUniverse
originally posted by: Pardon?
...
She is and has done absolutely nothing in the field she's criticising.
So, can you tell me why she's an expert or not.
Simple question.
I don't know maybe because of the fact that she has done research and published work on medical journals on substances that can cause toxicity?
But since this discussion of Dr. K Brogan is getting nowhere perhaps you should tell us why your "claimed expertise in cardiac rhythm management" give your claims more validity than those of other researchers who have even more extensive expertise than Dr. Brogan such as Laszlo Magos M.D. who has at least 163 published papers in pubmed.gov.
www.ncbi.nlm.nih.gov...
originally posted by: Pardon?
originally posted by: ElectricUniverse
originally posted by: Pardon?
Hopefully no-one anywhere gives the flu shot intranasally.
However, FluMist is used extensively in the US and other parts of the world which weakens your point quite a bit.
What the hell... Your point has been that VACCINES are safe despite evidence to the contrary, apart from your claims that only "you" can tell who can count as an expert.
Just because "people can get flu shot intranasally" doesn't make "VACCINES SAFE"...
The science shows they're safe.
Just because your belief system gets in the way of understanding that science doesn't make them unsafe.
originally posted by: AmenStop
originally posted by: Pardon?
originally posted by: ElectricUniverse
originally posted by: Pardon?
Hopefully no-one anywhere gives the flu shot intranasally.
However, FluMist is used extensively in the US and other parts of the world which weakens your point quite a bit.
What the hell... Your point has been that VACCINES are safe despite evidence to the contrary, apart from your claims that only "you" can tell who can count as an expert.
Just because "people can get flu shot intranasally" doesn't make "VACCINES SAFE"...
The science shows they're safe.
Just because your belief system gets in the way of understanding that science doesn't make them unsafe.
Sure, and science showed asbestos was safe, so safe that the government put it everywhere, and even after years of people getting sick they still claimed it was safe. why? because once the truth comes out, then they are liable, just like with vaccines.
John Jay Gargus
Positions:
Professor, Physiology & Biophysics
School of Medicine
Professor, Pediatrics
School of Medicine
Director of Center for Autism Research and Treatment (UCI CART)
School of Medicine
...
Matthew P. Anderson, MD, PhD, is an Associate Professor and Principal Investigator in the Departments of Pathology and Neurology and Director of Neuropathology at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School." The Anderson Laboratory studies the molecular, cellular and neural network mechanisms responsible for disorders of membrane excitability and synaptic transmission in the central nervous system.
...
Amber Clausi
Senior Process Engineer at Sanofi Pasteur
Allentown, Pennsylvania Area Pharmaceuticals
Amber Clausi's Overview
Current Senior Process Engineer at Sanofi Pasteur
Past Development Scientist at Sanofi Pasteur
Development Scientist at Sanofi Pasteur
Research Assistant at University of Colorado
see all
Education University of Colorado Boulder
Penn State University
...
Amber Clausi's Summary
Senior Process Engineer working on scale up/lyophilizaton cycle transfers of various vaccine products.
Specialties: Lyophilization, Vaccine Formulation and Stability, Aluminum Adjuvants, Stability Programs
...
José G. Dórea, Ph.D.
Professor of Nutritional Sciences, University of Brasília
A graduate from the University of Pernambuco with advanced degrees from the University of Massachusetts (MSc and PhD). He has worked at Iowa State University (USA), University of Hawaii (USA), and University of Campinas (Brazil). He is author of book chapters and has published on infant nutrition and environmental impact of toxic (natural and man made) substances on growth and development of children. He is in the Editorial Board of peer-reviewed scientific journals and has authored and co-authored more than 180 papers; 75 since 2007 in journals of public health, medical and environmental sciences, toxicology, and pharmacology.
...
Kathleen McCarty, Ph.D.
Superfund Research Program
Dr. Kathleen M. McCarty, an SRP trainee from 2002-2005, is an environmental/molecular epidemiologist at Yale University. She received her Doctor of Science degree (ScD) from the Department of Environmental Health Sciences at the Harvard School of Public Health (HSPH). Her dissertation research, a component of Dr. David C. Christiani's SRP-funded research project, "Arsenic and Health in Taiwan and Bangladesh", focused on whether environmental co-exposures and host factors affected arsenic biomarker response and/or susceptibility to arsenic-related skin lesions in Bangladesh. This work resulted in five peer-reviewed first author publications.
...
originally posted by: Pardon?
a reply to: ElectricUniverse
Oh dear.
You've not been reading properly again (which isn't surprising since you're still banging on about my claiming to be an expert which, if you get a grown-up to read my posts for you, they'll point out to you that I haven't claimed that at all)
...
originally posted by: ElectricUniverse
your claims that none of the research I have posted links to refutes your claims and do not come from experts, which I have proven is a lie,
so far I have given around 20 which dispute your claims.
originally posted by: CardiffGiant
...
Board Certified in Integrative Holistic Medicine, ABIHM
^^^^on what planet does that make her an expert on vaccines
...
John Jay Gargus
Positions:
Professor, Physiology & Biophysics
School of Medicine
Professor, Pediatrics
School of Medicine
Director of Center for Autism Research and Treatment (UCI CART)
School of Medicine
...
Matthew P. Anderson, MD, PhD, is an Associate Professor and Principal Investigator in the Departments of Pathology and Neurology and Director of Neuropathology at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School." The Anderson Laboratory studies the molecular, cellular and neural network mechanisms responsible for disorders of membrane excitability and synaptic transmission in the central nervous system.
...
Amber Clausi
Senior Process Engineer at Sanofi Pasteur
Allentown, Pennsylvania Area Pharmaceuticals
Amber Clausi's Overview
Current Senior Process Engineer at Sanofi Pasteur
Past Development Scientist at Sanofi Pasteur
Development Scientist at Sanofi Pasteur
Research Assistant at University of Colorado
see all
Education University of Colorado Boulder
Penn State University
...
Amber Clausi's Summary
Senior Process Engineer working on scale up/lyophilizaton cycle transfers of various vaccine products.
Specialties: Lyophilization, Vaccine Formulation and Stability, Aluminum Adjuvants, Stability Programs
...
José G. Dórea, Ph.D.
Professor of Nutritional Sciences, University of Brasília
A graduate from the University of Pernambuco with advanced degrees from the University of Massachusetts (MSc and PhD). He has worked at Iowa State University (USA), University of Hawaii (USA), and University of Campinas (Brazil). He is author of book chapters and has published on infant nutrition and environmental impact of toxic (natural and man made) substances on growth and development of children. He is in the Editorial Board of peer-reviewed scientific journals and has authored and co-authored more than 180 papers; 75 since 2007 in journals of public health, medical and environmental sciences, toxicology, and pharmacology.
...
Kathleen McCarty, Ph.D.
Superfund Research Program
Dr. Kathleen M. McCarty, an SRP trainee from 2002-2005, is an environmental/molecular epidemiologist at Yale University. She received her Doctor of Science degree (ScD) from the Department of Environmental Health Sciences at the Harvard School of Public Health (HSPH). Her dissertation research, a component of Dr. David C. Christiani's SRP-funded research project, "Arsenic and Health in Taiwan and Bangladesh", focused on whether environmental co-exposures and host factors affected arsenic biomarker response and/or susceptibility to arsenic-related skin lesions in Bangladesh. This work resulted in five peer-reviewed first author publications.
...
originally posted by: CardiffGiant
your links didnt come from experts though and your 20 or so links are from unqualified experts that deal in junk science...
just saying
originally posted by: ElectricUniverse
. What I have said is that she has published research on some substances that can cause toxicity and that is a fact.
PArdon wants to claim that no one should listen to what Drs. like Brogan have to say because "she is not an expert in vaccines".
BTW, I have already shown some of the experts n vaccines which refutes the blind and uninformed claims made by you and Pardon.
And a myriad of other specialists all who say that vaccines are not as safe as "some people" want you to believe...
These are just some of the research specialists whose research I have linked, and who state that there are substances in vaccines which are not safe...
originally posted by: ElectricUniverse
only experts in vaccines can make an informed decision on this topic, despite the fact that "PARDON" himself/herself IS NOT A VACCINE EXPERT, and I am sure that neither are you... If you two, and others like you are going to try to "nickpick" as to who can make an informed decision on this topic, then you two should leave yourselves out of the conversation because neither of you are qualified to do so.
...
Abstract: While evidence points to a multigenic etiology of most autism, the pathophysiology of the disorder has yet to be defined and the underlying genes and biochemical pathways they subserve remain unknown. Autism is considered to be influenced by a combination of various genetic, environmental and immunological factors; more recently, evidence has suggested that increased vulnerability to oxidative stress may be involved in the etiology of this multifactorial disorder.
...
© 2008 Science Publications
Corresponding Author: Matthew P. Anderson, Departments of Neurology and Pathology,
Harvard Medical School/Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine,
Room 846, 77 Avenue Louis Pasteur, Boston, MA 02115 USA, Tel: 6176670853
167
Bridging from Cells to Cognition in Autism Pathophysiology: Biological
Pathways to Defective Brain Function and Plasticity
1Matthew P. Anderson, 2Brian S. Hooker and 3Martha R. Herbert
1Departments of Neurology and Pathology, Harvard Medical School/Beth Israel Deaconess Medical
Center, Harvard Institutes of Medicine, Room 846, 77 Avenue Louis Pasteur, Boston, MA 02115 USA
2High Throughput Biology Team, Fundamental Science Directorate, Pacific Northwest National
Laboratory, 902 Battelle Blvd., Richland, WA 99354 USA
3Pediatric Neurology/Center for Morphometric Analysis, Massachusetts General Hospital/Harvard
Medical School, 149 13th St., Room 6012, Charlestown, MA 02129 USA
and
Center for Child and Adolescent Development, Cambridge Health Alliance/Harvard Medical School,
101 Station Landing, Room 2105, Medford, MA 02155 USA
Abstract: We review evidence to support a model where the disease process underlying autism may begin when an in utero or early postnatal environmental, infectious, seizure, or autoimmune insult triggers an immune response that increases reactive oxygen species (ROS) production in the brain that leads to DNA damage (nuclear and mitochondrial) and metabolic enzyme blockade and that these inflammatory and oxidative stressors persist beyond early development (with potential further exacerbations), producing ongoing functional consequences. In organs with a high metabolic demand such as the central nervous system, the continued use of mitochondria with damaged DNA and impaired metabolic enzyme function may generate additional ROS which will cause persistent activation of the innate immune system leading to more ROS production. Such a mechanism would self-sustain and possibly progressively worsen.
...
J Immunotoxicol. 2013 Apr-Jun;10(2):210-22. doi: 10.3109/1547691X.2012.708366. Epub 2012 Sep 11.
How aluminum adjuvants could promote and enhance non-target IgE synthesis in a genetically-vulnerable sub-population.
Terhune TD1, Deth RC.
Author information
Abstract
Aluminum-containing adjuvants increase the effectiveness of vaccination, but their ability to augment immune responsiveness also carries the risk of eliciting non-target responses, especially in genetically susceptible individuals. This study reviews the relevant actions of aluminum adjuvants and sources of genetic risk that can combine to adversely affect a vulnerable sub-population. Aluminum adjuvants promote oxidative stress and increase inflammasome activity, leading to the release of IL-1β, IL-18, and IL-33, but not the important regulatory cytokine IL-12. In addition, they stimulate macrophages to produce PGE₂, which also has a role in regulating immune responses. This aluminum-induced cytokine context leads to a T(H)2 immune response, characterized by the further release of IL-3, IL-4, IL-5, IL-9, IL-13, and IgE-potentiating factors such as sCD23. Genetic variants in cytokine genes, such as IL-4, IL-13, IL-33, and IL-18 influence the response to vaccines in children and are also associated with atopy. These genetic factors may therefore define a genetically-vulnerable sub-population, children with a family history of atopy, who may experience an exaggerated T(H)2 immune response to aluminum-containing vaccines. IL-4, sCD23, and IgE are common factors for both atopy and the immune-stimulating properties of aluminum adjuvants. IL-4 is critical in the production of IgE and total IgE up-regulation. IL-4 has also been reported to induce the production of sCD23 and trigger resting sIgM+, sIgD+ B-cells to switch to sIgE+ B-cells, making them targets for IgE-potentiating factors. Further, the actions of IgE-potentiating factors on sIgE+ B-cells are polyclonal and unrestricted, triggering their differentiation into IgE-forming plasma cells. These actions provide a mechanism for aluminum-adjuvant promotion and enhancement of non-target IgE in a genetically vulnerable sub-population. Identification of these individuals may decrease the risk of adverse events associated with the use of aluminum-containing vaccines.